These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 29353716)

  • 1. Hypovascular hypointense nodules in hepatobiliary phase without T2 hyperintensity: long-term outcomes and added value of DWI in predicting hypervascular transformation.
    Yang HJ; Song JS; Choi EJ; Choi H; Yang JD; Moon WS
    Clin Imaging; 2018; 50():123-129. PubMed ID: 29353716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypovascular hypointense nodules on hepatobiliary phase without T2 hyperintensity on gadoxetic acid-enhanced MR images in patients with chronic liver disease: long-term outcomes and risk factors for hypervascular transformation.
    Kim YS; Song JS; Lee HK; Han YM
    Eur Radiol; 2016 Oct; 26(10):3728-36. PubMed ID: 26670318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypovascular hypointense nodules on hepatobiliary phase gadoxetic acid-enhanced MR images in patients with cirrhosis: potential of DW imaging in predicting progression to hypervascular HCC.
    Kim YK; Lee WJ; Park MJ; Kim SH; Rhim H; Choi D
    Radiology; 2012 Oct; 265(1):104-14. PubMed ID: 22891358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-Hypervascular Hypointense Nodules at Gadoxetic Acid MRI: Hepatocellular Carcinoma Risk Assessment with Emphasis on the Role of Diffusion-Weighted Imaging.
    Briani C; Di Pietropaolo M; Marignani M; Carbonetti F; Begini P; David V; Iannicelli E
    J Gastrointest Cancer; 2018 Sep; 49(3):302-310. PubMed ID: 28547117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypovascular nodules in patients with chronic liver disease: risk factors for development of hypervascular hepatocellular carcinoma.
    Hyodo T; Murakami T; Imai Y; Okada M; Hori M; Kagawa Y; Kogita S; Kumano S; Kudo M; Mochizuki T
    Radiology; 2013 Feb; 266(2):480-90. PubMed ID: 23362095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging features of subcentimeter hypointense nodules on gadoxetic acid-enhanced hepatobiliary phase MR imaging that progress to hypervascular hepatocellular carcinoma in patients with chronic liver disease.
    Jang KM; Kim SH; Kim YK; Choi D
    Acta Radiol; 2015 May; 56(5):526-35. PubMed ID: 24838304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-hypervascular Hypointense Nodules on Hepatocyte Phase Gadoxetic Acid-Enhanced MR Images: Transformation of MR Hepatobiliary Hypointense Nodules into Hypervascular Hepatocellular Carcinomas.
    Cho YK; Kim JW; Kim MY; Cho HJ
    Gut Liver; 2018 Jan; 12(1):79-85. PubMed ID: 28798287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypervascular hepatocellular carcinoma 1 cm or smaller in patients with chronic liver disease: characterization with gadoxetic acid-enhanced MRI that includes diffusion-weighted imaging.
    Kim JE; Kim SH; Lee SJ; Rhim H
    AJR Am J Roentgenol; 2011 Jun; 196(6):W758-65. PubMed ID: 21606265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence for progression of hypervascular HCC in hypovascular hepatic nodules showing hyperintensity on gadoxetic acid-enhanced hepatobiliary phase in patients with chronic liver diseases.
    Matsuda M; Tsuda T; Yoshioka S; Murata S; Tanaka H; Hirooka M; Hiasa Y; Mochizuki T
    Jpn J Radiol; 2014 Jul; 32(7):405-13. PubMed ID: 24854900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonhypervascular Hypointense Nodules at Gadoxetic Acid-enhanced MR Imaging in Chronic Liver Disease: Diffusion-weighted Imaging for Characterization.
    Hwang J; Kim YK; Jeong WK; Choi D; Rhim H; Lee WJ
    Radiology; 2015 Jul; 276(1):137-46. PubMed ID: 25734551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of diffusion-weighted imaging and gadoxetic acid-enhanced MR images in the evaluation of hepatocellular carcinoma and hypovascular hepatocellular nodules.
    Di Pietropaolo M; Briani C; Federici GF; Marignani M; Begini P; Delle Fave G; Iannicelli E
    Clin Imaging; 2015; 39(3):468-75. PubMed ID: 25748089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.
    Lee MH; Kim SH; Park MJ; Park CK; Rhim H
    AJR Am J Roentgenol; 2011 Nov; 197(5):W868-75. PubMed ID: 22021534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural course of hypovascular nodules detected on gadoxetic acid-enhanced MR imaging: presence of fat is a risk factor for hypervascularization.
    Joishi D; Ueno A; Tanimoto A; Okuda S; Masugi Y; Emoto K; Okuma K; Sakamoto M; Imai Y; Kuribayashi S
    Magn Reson Med Sci; 2013 Dec; 12(4):281-7. PubMed ID: 24172788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presence of a hypovascular hepatic nodule showing hypointensity on hepatocyte-phase image is a risk factor for hypervascular hepatocellular carcinoma.
    Ichikawa S; Ichikawa T; Motosugi U; Sano K; Morisaka H; Enomoto N; Matsuda M; Fujii H; Araki T
    J Magn Reson Imaging; 2014 Feb; 39(2):293-7. PubMed ID: 23633285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypovascular hepatic nodules showing hypointense on the hepatobiliary-phase image of Gd-EOB-DTPA-enhanced MRI to develop a hypervascular hepatocellular carcinoma: a nationwide retrospective study on their natural course and risk factors.
    Inoue T; Hyodo T; Murakami T; Takayama Y; Nishie A; Higaki A; Korenaga K; Sakamoto A; Osaki Y; Aikata H; Chayama K; Suda T; Takano T; Miyoshi K; Koda M; Numata K; Tanaka H; Iijima H; Ochi H; Hirooka M; Imai Y; Kudo M
    Dig Dis; 2013; 31(5-6):472-9. PubMed ID: 24281023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of gadoxetic acid-enhanced MRI and diffusion-weighted imaging in the differentiation of hypervascular hyperplastic nodule from small (<3 cm) hypervascular hepatocellular carcinoma in patients with alcoholic liver cirrhosis: A retrospective case-control study.
    Kim SS; Kim SH; Song KD; Choi SY; Heo NH
    J Magn Reson Imaging; 2020 Jan; 51(1):70-80. PubMed ID: 31062483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kupffer phase image of Sonazoid-enhanced US is useful in predicting a hypervascularization of non-hypervascular hypointense hepatic lesions detected on Gd-EOB-DTPA-enhanced MRI: a multicenter retrospective study.
    Inoue T; Hyodo T; Korenaga K; Murakami T; Imai Y; Higaki A; Suda T; Takano T; Miyoshi K; Koda M; Tanaka H; Iijima H; Ochi H; Hirooka M; Numata K; Kudo M
    J Gastroenterol; 2016 Feb; 51(2):144-52. PubMed ID: 26373860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of diagnostic criteria using gadoxetic acid-enhanced and diffusion-weighted MR imaging for small hepatocellular carcinoma (<= 2.0 cm) in patients with hepatitis-induced liver cirrhosis.
    Park MJ; Kim YK; Lee MH; Lee JH
    Acta Radiol; 2013 Mar; 54(2):127-36. PubMed ID: 23148300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypervascular Transformation of Hypovascular Hypointense Nodules in the Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI: A Systematic Review and Meta-Analysis.
    Suh CH; Kim KW; Pyo J; Lee J; Kim SY; Park SH
    AJR Am J Roentgenol; 2017 Oct; 209(4):781-789. PubMed ID: 28742376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypovascular hepatic nodules at gadoxetic acid-enhanced MRI: whole-lesion hepatobiliary phase histogram metrics for prediction of progression to arterial-enhancing hepatocellular carcinoma.
    Rosenkrantz AB; Pinnamaneni N; Kierans AS; Ream JM
    Abdom Radiol (NY); 2016 Jan; 41(1):63-70. PubMed ID: 26830613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.